ENTRY       D05134                      Drug
NAME        Nelarabine (JAN/USAN/INN);
            Nelzarabine (USAN);
            Arranon (TN)
PRODUCT     ARRANON (Novartis Pharmaceuticals Corporation)
  GENERIC   NELARABINE (Amneal Pharmaceuticals LLC)
            NELARABINE (AqVida GmbH)
            NELARABINE (Dr. Reddy's Laboratories)
            NELARABINE (Meitheal Pharmaceuticals)
            NELARABINE (Shorla Oncology)
            NELARABINE (Zydus Lifesciences Limited)
            NELARABINE (Zydus Pharmaceuticals USA)
            NELARABINE (Zydus Pharmaceuticals USA)
FORMULA     C11H15N5O5
EXACT_MASS  297.1073
MOL_WEIGHT  297.2673
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
               DG01439  Arabinofuranosyl type antineoplastic
            Metabolizing enzyme substrate
             DG02983  ADA substrate
REMARK      Therapeutic category: 4229
            ATC code: L01BB07
            Product: D05134<JP/US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   T-cell acute lymphoblastic leukemia [DS:H00002]
            T-cell lymphoblastic lymphoma [DS:H00002]
TARGET      DNA polymerase
METABOLISM  Enzyme: ADA [HSA:100]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BB Purine analogues
                 L01BB07 Nelarabine
                  D05134  Nelarabine (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Nelarabine
                D05134  Nelarabine (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4229  Others
                 D05134  Nelarabine (JAN/USAN/INN); Nelzarabine (USAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG01439  Arabinofuranosyl type antineoplastic
                 D05134  Nelarabine
             Metabolizing enzyme substrate
              DG02983  ADA substrate
               D05134  Nelarabine
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D05134  Nelarabine
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05134
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05134
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05134
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05134
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D05134
DBLINKS     CAS: 121032-29-9
            PubChem: 47206859
            ChEBI: 63612
            LigandBox: D05134
ATOM        21
            1   N4y N    32.0322  -15.7888
            2   C8y C    33.0170  -16.6193
            3   C1y C    30.7477  -16.2037
            4   C8x C    32.6448  -14.4430
            5   C8y C    34.3294  -15.8362
            6   N5x N    33.0211  -18.0454
            7   O2x O    29.6092  -15.3511
            8   C1y C    30.3156  -17.4530
            9   N5x N    34.0857  -14.4471
            10  C8y C    35.5269  -16.5024
            11  C8y C    34.2787  -18.7580
            12  C1y C    28.4999  -16.1452
            13  C1y C    28.9320  -17.4530
            14  N5x N    35.5482  -17.9940
            15  O2a O    36.7096  -15.7885
            16  C1b C    27.1805  -15.7190
            17  O1a O    28.4882  -18.7723
            18  O1a O    26.1470  -16.6532
            19  N1a N    34.2969  -20.1733
            20  O1a O    31.1199  -18.5820
            21  C1a C    37.9346  -16.4642
BOND        23
            1     2   6 1
            2     3   7 1
            3     3   8 1
            4     4   9 2
            5     5  10 1
            6     6  11 2
            7     7  12 1
            8     8  13 1
            9    10  14 2
            10   10  15 1
            11   12  16 1 #Up
            12   13  17 1 #Down
            13   16  18 1
            14    5   9 1
            15   11  14 1
            16   12  13 1
            17    1   2 1
            18    3   1 1 #Up
            19    1   4 1
            20    2   5 2
            21   11  19 1
            22    8  20 1 #Up
            23   15  21 1
///
